Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in moderately active Crohn's disease
2005-000496-17Phase 2Completed
- Sponsor
- Region Skåne
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of atorvastatin in Crohn's disease, sponsored by Region Skåne. Primary endpoint: Effect of atorvastatin on active Crohn's disease. Started Feb 2005; status: completed.
02
Drugs
atorvastatin
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2005-000496-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000496-17.